Diacylglycerol Acyltransferase 2 Inhibitors (Janssen)

N/A

Report date: 2025/01/26 19:00:18
NME

Base Information

Drug NameDiacylglycerol Acyltransferase 2 Inhibitors (Janssen)
Drug Alias NameDGAT2 Inhibitor (Janssen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase 2 inhibitors
TargetsDiacylglycerol O-acyltransferase 2
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A